Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › LPA1R

LPA1R (1 companies · 1 programs)

Companies with an active program directed at LPA1R.

Structure Therapeutics Inc. GPCR

LTSE-2578 — Idiopathic Pulmonary Fibrosis Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.